Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| macrophage | 46 studies | 45% ± 15% | |
| conventional dendritic cell | 26 studies | 33% ± 13% | |
| classical monocyte | 24 studies | 38% ± 13% | |
| plasmacytoid dendritic cell | 22 studies | 59% ± 16% | |
| non-classical monocyte | 20 studies | 30% ± 17% | |
| monocyte | 19 studies | 36% ± 14% | |
| fibroblast | 19 studies | 36% ± 21% | |
| pericyte | 15 studies | 32% ± 15% | |
| dendritic cell | 13 studies | 41% ± 19% | |
| myeloid cell | 13 studies | 39% ± 13% | |
| smooth muscle cell | 12 studies | 28% ± 8% | |
| myofibroblast cell | 10 studies | 37% ± 15% | |
| connective tissue cell | 9 studies | 39% ± 9% | |
| alveolar macrophage | 7 studies | 26% ± 5% | |
| mononuclear phagocyte | 7 studies | 44% ± 17% | |
| leukocyte | 4 studies | 27% ± 7% | |
| basal cell | 4 studies | 39% ± 25% | |
| abnormal cell | 3 studies | 30% ± 7% | |
| tissue-resident macrophage | 3 studies | 61% ± 10% | |
| intermediate monocyte | 3 studies | 53% ± 10% | |
| inflammatory macrophage | 3 studies | 27% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| intestine | 96% | 7861.14 | 930 / 966 | 91% | 348.90 | 477 / 527 |
| lung | 99% | 9909.44 | 572 / 578 | 83% | 142.07 | 963 / 1155 |
| breast | 99% | 11176.57 | 455 / 459 | 75% | 79.55 | 841 / 1118 |
| liver | 86% | 5178.28 | 195 / 226 | 81% | 90.92 | 329 / 406 |
| skin | 100% | 103458.84 | 1809 / 1809 | 66% | 151.04 | 311 / 472 |
| uterus | 84% | 5706.22 | 142 / 170 | 74% | 175.50 | 340 / 459 |
| bladder | 86% | 11525.52 | 18 / 21 | 65% | 216.29 | 326 / 504 |
| stomach | 62% | 4864.35 | 223 / 359 | 87% | 236.46 | 250 / 286 |
| esophagus | 71% | 5086.15 | 1026 / 1445 | 74% | 153.29 | 135 / 183 |
| thymus | 82% | 4143.07 | 536 / 653 | 57% | 61.09 | 346 / 605 |
| kidney | 62% | 4337.56 | 55 / 89 | 73% | 453.85 | 661 / 901 |
| prostate | 90% | 6520.24 | 220 / 245 | 20% | 10.18 | 102 / 502 |
| adrenal gland | 86% | 4583.62 | 221 / 258 | 24% | 28.42 | 55 / 230 |
| adipose | 100% | 12961.31 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 17904.69 | 1330 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 99% | 8856.04 | 238 / 241 | 0% | 0 | 0 / 0 |
| ovary | 35% | 1901.36 | 63 / 180 | 61% | 60.44 | 264 / 430 |
| pancreas | 11% | 464.25 | 36 / 328 | 83% | 142.80 | 147 / 178 |
| tonsil | 0% | 0 | 0 / 0 | 84% | 161.73 | 38 / 45 |
| heart | 81% | 5030.54 | 698 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 64% | 3610.28 | 598 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 52% | 34.48 | 15 / 29 |
| brain | 2% | 96.92 | 65 / 2642 | 35% | 43.84 | 244 / 705 |
| muscle | 35% | 1293.76 | 279 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 15% | 9.04 | 12 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007601 | Biological process | visual perception |
| GO_0001525 | Biological process | angiogenesis |
| GO_0008283 | Biological process | cell population proliferation |
| GO_0002062 | Biological process | chondrocyte differentiation |
| GO_0007162 | Biological process | negative regulation of cell adhesion |
| GO_0030198 | Biological process | extracellular matrix organization |
| GO_0007155 | Biological process | cell adhesion |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0005802 | Cellular component | trans-Golgi network |
| GO_0005604 | Cellular component | basement membrane |
| GO_0005201 | Molecular function | extracellular matrix structural constituent |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005178 | Molecular function | integrin binding |
| GO_0050839 | Molecular function | cell adhesion molecule binding |
| GO_0050840 | Molecular function | extracellular matrix binding |
| GO_0005518 | Molecular function | collagen binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | TGFBI |
| Protein name | Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3) (Kerato-epithelin) (RGD-containing collagen-associated protein) (RGD-CAP) Transforming growth factor beta induced Transforming growth factor beta Transforming growth factor-beta-induced protein ig-h3 |
| Synonyms | BIGH3 |
| Description | FUNCTION: Plays a role in cell adhesion . May play a role in cell-collagen interactions (By similarity). . |
| Accessions | Q15582 C7FFS5 ENST00000509485.5 ENST00000508076.5 H0Y8L3 ENST00000442011.7 H0Y9D7 A0A0S2Z4K6 H0Y8M8 ENST00000604555.5 A0A0S2Z4Q2 ENST00000514554.5 H0YAB8 ENST00000503087.1 D6RBX4 H0YAH8 S4R3C6 ENST00000508767.5 ENST00000507018.5 |